Skip to content

CAPR

Capricor Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$19.50+0.31%

Price as of Jul 20, 2026

CAPR capital

Capricor Therapeutics, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.08x
Net debt / equity
-0.30x
Debt / assets
0.06x
Debt / EBITDA
0.02x
Net debt / EBITDA
-0.09x

Liquidity & coverage

Current ratio
8.42x
Quick ratio
8.42x
Cash ratio
8.28x
Interest coverage
-39.38x
EBITDA / interest
293.31x
Working capital
$249.5M

Cash & dividend

FCF / debt
-5.39x
Cash flow / debt
-4.39x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.